Home > Financial Ratios > CIPLA

CIPLA
Core EBITDA Growth

    Back to All Ratios
CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CIPLA
Please provide your vote to see the results

CIPLA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 27.9013.836.9827.27-0.66

What is the latest Core EBITDA Growth ratio of CIPLA ?

The latest Core EBITDA Growth ratio of CIPLA is 27.90 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202427.90
Mar202313.83
Mar20226.98
Mar202127.27
Mar2020-0.66

How is Core EBITDA Growth of CIPLA Trending?

Years Core EBITDA Growth % Change
Mar2024 27.9
101.74
Mar2023 13.83
98.14
Mar2022 6.98
-74.40
Mar2021 27.27
Positive
Mar2020 -0.66 -

Other Financial Ratios of CIPLA


Compare Core EBITDA Growth ratio of peers of CIPLA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CIPLA ₹122,927.9 Cr 2.2% 0.2% 2.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,824.0 Cr 0.5% -0.5% 14.6% Stock Analytics
DIVIS LABORATORIES ₹178,355.0 Cr 1.3% 10.7% 49.3% Stock Analytics
DR REDDYS LABORATORIES ₹112,701.0 Cr 4.7% 11.9% 14.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹108,502.0 Cr 2% -0.8% 15.7% Stock Analytics
MANKIND PHARMA ₹98,151.0 Cr 0.7% -6.7% 10.3% Stock Analytics


CIPLA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CIPLA

2.2%

0.2%

2.3%

SENSEX

1.9%

0.1%

10.9%


You may also like the below Video Courses